Paul Schmiedmayer

Paul Schmiedmayer

Auto-generated profile, based on publicly available information

Paul Schmiedmayer

Stanford Mussallem Center for Biodesign, Stanford University, Stanford, California, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025
Verified
Conference Paper
Open access
MJMatthew Jörke
Matthew Jörke
SSShardul Sapkota
Shardul Sapkota
LWLyndsea Warkenthien
Lyndsea Warkenthien
NVNiklas Vainio
Niklas Vainio
PSPaul Schmiedmayer
Paul Schmiedmayer
JLJames A. Landay
James A. Landay

3 April 2025 in Smart Health
Verified
Journal Article
Open access
PZPhilipp Zagar
Philipp Zagar
VRVishnu Ravi
Vishnu Ravi
LALauren Aalami
Lauren Aalami
SKStephan Krusche
Stephan Krusche
OAOliver Aalami
Oliver Aalami
PSPaul Schmiedmayer
Paul Schmiedmayer

13 December 2023 in Communications Medicine
Verified
Journal Article
Open access
PDF file
AZAydin Zahedivash
Aydin Zahedivash
HCHenry Chubb
Henry Chubb
HGHeather Giacone
Heather Giacone
NBNicole K. Boramanand
Nicole K. Boramanand
ADAnne M. Dubin
Anne M. Dubin
SCScott R. Ceresnak
Scott R. Ceresnak
Background: Arrhythmia symptoms are frequent complaints in children and often require a pediatric cardiology evaluation. Data regarding the clinical utility of wearable technologies are limited in children. We hypothesize that an Apple Watch can capture arrhythmias in children. Methods: We present an analysis of patients ≤18 years-of-age who had signs of an arrhythmia documented by an Apple Watch. We include patients evaluated at our center over a 4-year-period and highlight those receiving a formal arrhythmia diagnosis. We evaluate the role of the Apple Watch in arrhythmia diagnosis, the results of other ambulatory cardiac monitoring studies, and findings of any EP studies. Results: We identify 145 electronic-medical-record identifications of Apple Watch, and find arrhythmias confirmed in 41 patients (28%) [mean age 13.8 ± 3.2 years]. The arrythmias include: 36 SVT (88%), 3 VT (7%), 1 heart block (2.5%) and wide 1 complex tachycardia (2.5%). We show that invasive EP study confirmed diagnosis in 34 of the 36 patients (94%) with SVT (2 non-inducible). We find that the Apple Watch helped prompt a workup resulting in a new arrhythmia diagnosis for 29 patients (71%). We note traditional ambulatory cardiac monitors were worn by 35 patients (85%), which did not detect arrhythmias in 10 patients (29%). In 73 patients who used an Apple Watch for recreational or self-directed heart rate monitoring, 18 (25%) sought care due to device findings without any arrhythmias identified. Conclusion: We demonstrate that the Apple Watch can record arrhythmia events in children, including events not identified on traditionally used ambulatory monitors.

27 July 2024 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
SHShannon L. Hoffman
Shannon L. Hoffman
PSPaul Schmiedmayer
Paul Schmiedmayer
AGAryaman S. Gala
Aryaman S. Gala
KWKevin B. Wilkins
Kevin B. Wilkins
LPLaura Parisi
Laura Parisi
HBHelen Bronte-Stewart
Helen Bronte-Stewart
People with Parkinson’s disease (PWP) face critical challenges, including lack of access to neurological care, inadequate measurement and communication of motor symptoms, and suboptimal medication management and compliance. We have developed QDG-Care: a comprehensive connected care platform for Parkinson’s disease (PD) that delivers validated, quantitative metrics of all motor signs in PD in real time, monitors the effects of adjusting therapy and medication adherence and is accessible in the electronic health record. In this article, we describe the design and engineering of all components of QDG-Care, including the development and utility of the QDG Mobility and Tremor Severity Scores. We present the preliminary results and insights from an at-home trial using QDG-Care. QDG technology has enormous potential to improve access to, equity of, and quality of care for PWP, and improve compliance with complex time-critical medication regimens. It will enable rapid “Go-NoGo” decisions for new therapeutics by providing high-resolution data that require fewer participants at lower cost and allow more diverse recruitment.

14 May 2025 in JACC: Advances
Verified
Journal Article
Open access
PSPaul Schmiedmayer
Paul Schmiedmayer
ARAdrit Rao
Adrit Rao
PZPhilipp Zagar
Philipp Zagar
LALauren Aalami
Lauren Aalami
VRVishnu Ravi
Vishnu Ravi
OAOliver Aalami
Oliver Aalami
To improve healthcare quality and empower patients, federal legislation requires nationwide interoperability of electronic health records (EHRs) through Fast Healthcare Interoperability Resources (FHIR) application programming interfaces. Nevertheless, key barriers to patient EHR access-limited functionality, English, and health literacy-persist, impeding equitable access to these benefits. This study aimed to develop and evaluate a digital health solution to address barriers preventing patient engagement with personal health information, focusing on individuals managing chronic cardiovascular conditions. We present LLMonFHIR, an open-source mobile application that uses large language models (LLMs) to allow users to "interact" with their health records at any degree of complexity, in various languages, and with bidirectional text-to-speech functionality. In a pilot evaluation, physicians assessed LLMonFHIR responses to queries on 6 SyntheticMass FHIR patient datasets, rating accuracy, understandability, and relevance on a 5-point Likert scale. A total of 210 LLMonFHIR responses were evaluated by physicians, receiving high median scores for accuracy (5/5), understandability (5/5), and relevance (5/5). Challenges summarizing health conditions and retrieving lab results were noted, with variability in responses and occasional omissions underscoring the need for precise preprocessing of data. LLMonFHIR's ability to generate responses in multiple languages and at varying levels of complexity, along with its bidirectional text-to-speech functionality, give it the potential to empower individuals with limited functionality, English, and health literacy to access the benefits of patient-accessible EHRs.

4 July 2023 in JAMIA Open
Verified
Journal Article
Open access
PDF file
OAOliver Aalami
Oliver Aalami
MHMike Hittle
Mike Hittle
VRVishnu Ravi
Vishnu Ravi
AGAshley Griffin
Ashley Griffin
PSPaul Schmiedmayer
Paul Schmiedmayer
RVRoss Venook
Ross Venook
Smartphone devices capable of monitoring users’ health, physiology, activity, and environment revolutionize care delivery, medical research, and remote patient monitoring. Such devices, laden with clinical-grade sensors and cloud connectivity, allow clinicians, researchers, and patients to monitor health longitudinally, passively, and persistently, shifting the paradigm of care and research from low-resolution, intermittent, and discrete to one of persistent, continuous, and high resolution. The collection, transmission, and storage of sensitive health data using mobile devices presents unique challenges that serve as significant barriers to entry for care providers and researchers alike. Compliance with standards like HIPAA and GDPR requires unique skills and practices. These requirements make off-the-shelf technologies insufficient for use in the digital health space. As a result, budget, timeline, talent, and resource constraints are the largest barriers to new digital technologies. The CardinalKit platform is an open-source project addressing these challenges by focusing on reducing these barriers and accelerating the innovation, adoption, and use of digital health technologies. CardinalKit provides a mobile template application and web dashboard to enable an interoperable foundation for developing digital health applications. We demonstrate the applicability of CardinalKit to a wide variety of digital health applications across 18 innovative digital health prototypes.